ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
107 hedge funds and large institutions have $621M invested in Albireo Pharma, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 23 closing their positions.
Holders
107
Holders Change
-1
Holders Change %
-0.93%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
44
Reduced
30
Closed
23
Calls
$1.87M
Puts
$5.87M
Net Calls
-$4M
Net Calls Change
+$40.1M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$33.2M |
2 |
2
State Street
Boston,
Massachusetts
|
$29.3M |
3 |
3
BlackRock
New York
|
$46.6M |
4 |
4
Goldman Sachs
New York
|
$8.18M |
5 |
RHJA
5
Rice Hall James & Associates
San Diego,
California
|
$9.65M |